CATALAYER NEWS
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
Source: Bloomberg Markets · 2026-07-29
Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases with high unmet need, is seeking to raise as much as $212.5 million in a US initial public offering.
MORE FROM BLOOMBERG MARKETS
India Billionaire Family Offices Offer Profit-Sharing to Attract Top Talent
2026-07-31
Egypt Unlocks About $1.8 Billion IMF Payout After Passing Review
2026-07-31
Top India Fund Manager Favors Banks, Power as Oil Risks Loom
2026-07-31
Japan Declines to Confirm Yen Intervention, Hints at US Support
2026-07-31
Hong Kong Resurrects China Bond Futures With Liquidity in Focus
2026-07-31
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets